Comparing Careview Communications (OTCMKTS:CRVW) and Pulmonx (NASDAQ:LUNG)

Pulmonx (NASDAQ:LUNGGet Free Report) and Careview Communications (OTCMKTS:CRVWGet Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, earnings and dividends.

Insider & Institutional Ownership

91.0% of Pulmonx shares are held by institutional investors. 6.8% of Pulmonx shares are held by company insiders. Comparatively, 63.9% of Careview Communications shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of recent recommendations for Pulmonx and Careview Communications, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pulmonx 1 4 5 0 2.40
Careview Communications 0 0 0 0 0.00

Pulmonx presently has a consensus target price of $6.81, suggesting a potential upside of 176.71%. Given Pulmonx’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Pulmonx is more favorable than Careview Communications.

Risk & Volatility

Pulmonx has a beta of 0.22, meaning that its share price is 78% less volatile than the S&P 500. Comparatively, Careview Communications has a beta of -0.5, meaning that its share price is 150% less volatile than the S&P 500.

Profitability

This table compares Pulmonx and Careview Communications’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Pulmonx -61.91% -77.58% -37.90%
Careview Communications -39.94% N/A -78.17%

Earnings and Valuation

This table compares Pulmonx and Careview Communications”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Pulmonx $83.79 million 1.21 -$56.39 million ($1.41) -1.74
Careview Communications $8.25 million N/A -$4.70 million N/A N/A

Careview Communications has lower revenue, but higher earnings than Pulmonx.

Summary

Pulmonx beats Careview Communications on 7 of the 11 factors compared between the two stocks.

About Pulmonx

(Get Free Report)

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

About Careview Communications

(Get Free Report)

CareView Communications, Inc. provides video monitoring solutions in the United States. Its products include CareView Patient Safety System, a video monitoring tool to improve the practice of nursing, create a better work environment, and make the patient's hospital stay more satisfying, which is used in hospitals, nursing homes, adult living centers, and outpatient care facilities; and CareView Connect, which provides resident monitoring products and services for the long- term care industry; an array of wearable and stationary buttons that allow a resident to summon help either for an emergency or assistance; a mobile app capable of delivering an alert to the caregiver and allows them document information around that alert; and alert management and monitoring system that provides a suite of hardware and software to facilitate a data-driven solution for alert management and monitoring. The company also offers Caregiver Platform that offers caregiver connect mobile application to provide a convenient and intuitive interface to capture critical workflows, such as acknowledging and documenting alert presses by the resident. In addition, it provides SitterView and TeleMedView that allows hospital staff to use CareView's video cameras to observe and communicate with patients remotely. CareView Communications, Inc. is based in Lewisville, Texas.

Receive News & Ratings for Pulmonx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulmonx and related companies with MarketBeat.com's FREE daily email newsletter.